Article 08 Apr 2022 FDA Issues Draft Guidance On Human Gene Therapy Products Incorporating Human Genome Editing United States Healthcare
Article 06 Apr 2022 QMSR: Welcomed By The Industry, But Lacking In Practicality United States Healthcare
Article 17 Mar 2022 New Jersey Court Affirms Prohibition Of Physician Practice From Opening And Operating In-Office Pharmacy United States Healthcare
Article 14 Mar 2022 FDA's Loud And Clear Message: Engage With FDA Early And Formally United States Healthcare
Article 10 Mar 2022 Quality Management System Regulation (QMSR) – Harmonizing The Quality System Regulation (QSR) With ISO 13485:2016 United States Healthcare
Article 21 Feb 2022 FDA Releases Draft Guidance On Digital Health Technologies For Remote Data Acquisition In Clinical Investigations United States Healthcare
Article 16 Feb 2022 FDA Releases Draft Guidance On Use Of Real-World Evidence For Drug & Biological Products United States Healthcare
Article 28 Jan 2022 FDA Oks Mail-Order Mifepristone: State Laws May Inhibit Its Use United States Healthcare
Article 29 Dec 2021 De Novo Classification Final Rule To Take Effect Next Year United States Healthcare
Article 29 Dec 2021 3 Key Takeaways From FDLI's FDA Center Compliance Directors: Presentations And Q&A Session United States Healthcare